Your browser doesn't support javascript.
loading
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.
Dickler, Maura N; Saura, Cristina; Richards, Donald A; Krop, Ian E; Cervantes, Andrés; Bedard, Philippe L; Patel, Manish R; Pusztai, Lajos; Oliveira, Mafalda; Cardenas, Alison K; Cui, Na; Wilson, Timothy R; Stout, Thomas J; Wei, Michael C; Hsu, Jerry Y; Baselga, José.
Afiliação
  • Dickler MN; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. Dickler_maura@lilly.com.
  • Saura C; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Richards DA; Medical Oncology, Texas Oncology-Tyler, US Oncology Research, Woodlands, Texas.
  • Krop IE; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cervantes A; CIBERONC, Medical Oncology Department, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain.
  • Bedard PL; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida.
  • Pusztai L; Yale Cancer Center, Breast Medical Oncology, New Haven, Connecticut.
  • Oliveira M; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Cardenas AK; Genentech, Inc., South San Francisco, California.
  • Cui N; Genentech, Inc., South San Francisco, California.
  • Wilson TR; Genentech, Inc., South San Francisco, California.
  • Stout TJ; Genentech, Inc., South San Francisco, California.
  • Wei MC; Genentech, Inc., South San Francisco, California.
  • Hsu JY; Genentech, Inc., South San Francisco, California.
  • Baselga J; Breast Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin Cancer Res ; 24(18): 4380-4387, 2018 09 15.
Article em En | MEDLINE | ID: mdl-29793946
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazepinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Classe I de Fosfatidilinositol 3-Quinases / Imidazóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazepinas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Classe I de Fosfatidilinositol 3-Quinases / Imidazóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article